Thoracolaryngopelvic dysplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3317OMIM:187760Q77.2
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Thoracolaryngopelvic dysplasia, also known as Barnes syndrome, is an extremely rare skeletal dysplasia characterized by a distinctive combination of thoracic, laryngeal, and pelvic abnormalities. The condition primarily affects the skeletal system, with key features including a short thorax (narrow, bell-shaped chest), laryngeal stenosis (narrowing of the airway at the level of the larynx), and pelvic bone abnormalities. The short ribs and narrow thorax can lead to restrictive lung disease and respiratory insufficiency, which may be life-threatening in the neonatal period. Laryngeal involvement can cause stridor (noisy breathing) and airway obstruction, further compounding respiratory difficulties. Additional skeletal features may include short stature, shortened long bones, and characteristic radiographic changes in the pelvis such as small iliac wings. The condition shares clinical overlap with other short-rib dysplasias, including asphyxiating thoracic dystrophy (Jeune syndrome), but is distinguished by the prominent laryngeal stenosis component. Some patients may also develop renal complications. Treatment is primarily supportive and symptomatic. Management of airway compromise may require tracheostomy or other surgical interventions to maintain adequate ventilation. Respiratory support and monitoring of pulmonary function are essential components of care. Orthopedic management may be needed for skeletal complications. The prognosis depends largely on the severity of thoracic and airway involvement, with early respiratory failure being the most significant risk. Only a very small number of cases have been reported in the medical literature, limiting comprehensive understanding of the full clinical spectrum and long-term outcomes.

Also known as:

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Thoracolaryngopelvic dysplasia.

View clinical trials →

No actively recruiting trials found for Thoracolaryngopelvic dysplasia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Thoracolaryngopelvic dysplasia community →

No specialists are currently listed for Thoracolaryngopelvic dysplasia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Thoracolaryngopelvic dysplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Thoracolaryngopelvic dysplasiaForum →

No community posts yet. Be the first to share your experience with Thoracolaryngopelvic dysplasia.

Start the conversation →

Latest news about Thoracolaryngopelvic dysplasia

No recent news articles for Thoracolaryngopelvic dysplasia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Thoracolaryngopelvic dysplasia

What is Thoracolaryngopelvic dysplasia?

Thoracolaryngopelvic dysplasia, also known as Barnes syndrome, is an extremely rare skeletal dysplasia characterized by a distinctive combination of thoracic, laryngeal, and pelvic abnormalities. The condition primarily affects the skeletal system, with key features including a short thorax (narrow, bell-shaped chest), laryngeal stenosis (narrowing of the airway at the level of the larynx), and pelvic bone abnormalities. The short ribs and narrow thorax can lead to restrictive lung disease and respiratory insufficiency, which may be life-threatening in the neonatal period. Laryngeal involvemen

How is Thoracolaryngopelvic dysplasia inherited?

Thoracolaryngopelvic dysplasia follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Thoracolaryngopelvic dysplasia typically begin?

Typical onset of Thoracolaryngopelvic dysplasia is neonatal. Age of onset can vary across affected individuals.